Laura Brege, Director at Pacira BioSciences, Inc. (PCRX), bought 1,000 shares at $12.81 ($13K) on 2024-08-16, disclosed to the SEC on 2024-08-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |
| PCRX | SELL | 2023-04-05 | $285K | — | Filing → |